















































































































































































































































































































































































































































































































































































	≤50	y	 383	 151	 491	 237	 15	 1277	
	>50	y	 394	 75	 1238	 185	 209	 2101	
Gender	
	Males		 356	 135	 1098	 185	 130	 1906	
	Females	 421	 95	 814	 257	 94	 1681	
Functional	status		
	yes	 4	 20	 47	 3	 3	 77	
	no	 n/a	 2	 118	 3	 n/a	 123	
unknown	 31	 0	 82	 9	 47	 169	
Grade,	G	(WHO)	
	G1	and	G2	 n/a	 21	 149	 9	 29	 208	
	G3	 n/a	 1	 6	 2	 1	 10	
unknown	 35	 0	 12	 4	 20	 71	
Stage	(ENETS)	
	I	/	II	/	III	 17	 n/a	 133	 12	 n/a	 162	
	IV	 5	 n/a	 32	 2	 n/a	 39	
unknown	 13	 22	 82	 1	 50	 168	
Total	cases	 35	 22	 247	 15	 50	 369	







































































































































































































































































Locus	 Gene	 SNP	 Genotype	groups	 OR	(95%	CI)a	 P	
Grade	(G1/G2/well	differentiated	tumors	vs.	G3/poorly	differentiated	tumors)	
1q32.1	 NR5A2	 rs10919791	 GG/GA/AA	115/38/15	 5.66	(1.18-27.11)†	 0.03	






8q24.21	 MIR1208,	PVT1	 rs1561927	 CC/TC/TT	18/55/95	 2.39	(1.18-4.85)†	 0.02	
3q28	 TP63	 rs9854771	 AA/GA/GG	22/67/81	 0.44	(0.22-0.90)†	 0.02	






12q24.21	 HNF1A	 rs7310409	 AA/GA/GG	32/79/66	 0.36	(0.16-0.79)†	 0.01	

















Log2	fold-change	 P	 Adjusted-P*	 Log2	fold-change	 P	 Adjusted-P*	
MYC	 4.38	 9.47x10-7	 5.88x10-5	 2.65	 4.55x10-4	 5.93x10-3	
NR5A2	 4.91	 7.82x10-10	 2.38x10-7	 3.51	 2.00x10-4	 3.31x10-3	
KLF5	 1.69	 1.59x10-2	 6.96x10-2	 -1.41	 1.59x10-1	 3.18x10-1	
CTRB1	 7.90	 1.10x10-9	 3.04x10-7	 7.55	 2.56x10-8	 5.18x10-6	
CTRB2	 7.70	 6.75x10-8	 8.08x10-6	 7.33	 1.71x10-6	 1.13x10-4	
PDX1	 0.72	 3.58x10-1	 5.49x10-1	 2.43	 1.18x10-3	 1.16x10-2	
*	P-value	adjusted	using	Benjamini	&	Hochberg	method	(False	discovery	rate)	
Based	on	predefined	cutoff	value	of	Adjusted-P	<	0.05	and	|log2	fold-change|	>	1,	genes	which	are	differentially	expressed	in	both	groups	are	in	
bold.	
	
